The violence in Mexico following the killing of the head of a drug cartel illustrates again the failure of the War on Drugs.

The new advisory group is charged with developing evidence- and consensus-based recommendations on prevention and harm-reduction strategies ...

Drug kingpin Nemesio “El Mencho” Oseguera Cervantes may be dead, but the Jalisco cartel he ran for years will likely outlive ...

President Donald Trump is urging Congress to turn his most-favored-nation drug-pricing deals into law, but Republicans don’t seem too keen on codifying his deals with drugmakers.

The bill, listed as YBHA No. 31, passed second reading this week and has moved to the committee stage, with public hearings scheduled for 8 and 9 MarchThe Yobe State House of Assembly has advanced a ...

President Trump last week suggested that a second reconciliation bill is not needed this year, but because the national debt is at $38 trillion and growing, policymakers need to act with a sense of ...

Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from ...

The future of the U.S. Preventive Services Task Force ‘remains unclear,’ and the threat to its structure and scientific processes “have implications for millions of Americans,” according to former ...

The first-ever White House drug czar says that while he loves President Donald Trump and “almost everything he does,” that affection doesn’t extend to the pending proposal to federally reschedule ...

A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and ...

Analysis highlights how regulatory divergence in two major pharmaceutical markets could shape future access to emerging ...